Stimulant Use Disorder Clinical Trials
2 recruiting trials for Stimulant Use Disorder. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Stimulant Use Disorder clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Elana Rosenthal (1), University of Texas Southwestern Medical Center (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Integrated Infectious Diseases and Substance Use Disorder Clinic (IC) (behavioral, 1 trial), followed by DynamiCare, Patient Navigation (PN).
Track Stimulant Use Disorder trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use...
RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
Justice-involved individuals face disproportionately high rates of stimulant use disorder and HIV, along with disrupted access to HIV treatment and prevention services like ART...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Stimulant Use Disorder, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Stimulant Use Disorder, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Stimulant Use Disorder, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.